Media Advisory - Medication analytics solution coming to Newfoundland and Labrador, a first in Canada

ST. JOHN'S, NL, June 20, 2022 /CNW/ - BD is hosting an event to announce the start of a medication analytics solution, which aims to reduce the use of antibiotics and other medications. This solution is being trialed at Eastern Health.

An event will take place at the Sheraton Hotel in St. John's, NL on June 22, 2022 to provide more details on this trial that will see this innovative technology being used in Canada for the first time.

Media are invited to attend the news conference in-person, or they can join virtually. Speakers and representatives will be available for interviews following the announcement.

No RSVP is required, although members of the media are encouraged to reach out in advance of the event to register and have their questions included in the Q&A.

Virtual participation

• Join us for the announcement through this link – registration will open at 10:00 a.m. NT (8:30 a.m. ET). Questions may be entered live via the chat.

Notable Event Attendees

• The Honourable John Haggie, Minister of Health and Community Services
• Dr. Peter Daley, Infectious Diseases Physician and Medical Microbiologist, Memorial University
• Dr. Kalvin Yu, Vice President, Medical & Scientific Affairs at BD
• Ivy Parks, BD–Canada President
• Ron Johnson, Vice President, Innovation and Rural Health, Eastern Health

About BD

BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of health care by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for health care providers. BD and its 70,000 employees have a passion and commitment to help enhance the safety and efficiency of clinicians' care delivery process, enable laboratory scientists to accurately detect disease and advance researchers' capabilities to develop the next generation of diagnostics and therapeutics. BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care. For more information on BD, please visit bd.com/en-ca or connect with us on LinkedIn at https://www.linkedin.com/company/bd1/ and Twitter @BDandCo.

SOURCE BD - Canada